PCM
NDRM

Prelude Capital Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Prelude Capital Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-400
Closed -$16K – 2012
2017
Q3 		$16K Buy
+400
New +$14.7K ﹤0.01% 1365

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Prelude Capital Management's NDRM Position: Q4 2017 in Review

Prelude Capital Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 91,533 shares — an estimated $3.56M sold.

Prelude Capital Management first reported a position in NDRM in Q4 2016 and held it in 3 quarters. The position peaked at $3.56M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Prelude Capital Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Prelude Capital Management sold 91,533 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $3.56M.
  • Prelude Capital Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2016 and held it in 3 quarters.
  • Prelude Capital Management's NeuroDerm Ltd. Ordinary Shares position peaked at $3.56M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.